Heart rate variability as a biomarker of anxious depression response to antidepressant medication

Depression and Anxiety

Volumn 36, Issue 1, 2019, Pages 63-71

  Kircanski, Katharina ^a   Williams, Leanne M ^a   Gotlib, Ian H ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

antidepressant; anxious depression; depression; heart rate variability; outcome; treatment

Indexed keywords

ESCITALOPRAM; SERTRALINE; VENLAFAXINE; ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; CITALOPRAM;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICIAN; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HEART FUNCTION; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED ANXIETY AND DEPRESSION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ADOLESCENT; AGED; ANXIETY; CLINICAL TRIAL; COMPLICATION; DEPRESSION; HEART RATE; MAJOR DEPRESSION; MIDDLE AGED; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANXIETY; BIOMARKERS; CITALOPRAM; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SERTRALINE; TREATMENT OUTCOME; VENLAFAXINE HYDROCHLORIDE; YOUNG ADULT;

EID: 85054850672     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22843     Document Type: Article

References (46)

1. Agelink, M. W., Majewski, T., Wurthmann, C., Postert, T., Linka, T., Rotterdam, S., & Klieser, E. (2001). Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone. Journal of Affective Disorders, 62, 187–198
2. Agelink, M. W., Ullrich, H., Baumann, B., Strum, S., & Majewski, T. (2002). Effects of reboxetine, a selective norepinephrine reuptake inhibitor, on sympathetic and parasympathetic outflow to the heart: Preliminary data. Psychopharmacology, 163, 151–156
3. Arnow, B. A., Blasey, C., Williams, L. M., Palmer, D. M., Rekshan, W., Schatzberg, A. F., … Rush, A. J. (2015). Depression subtypes in predicting antidepressant response: A report from the iSPOT-D trial. American Journal of Psychiatry, 172, 743–750
4. Berntson, G. G., Bigger, J. T., Eckberg, D. L., Grossman, P., Kaufmann, P. G., Malik, M., … van der Molen, M. W. (1997). Heart rate variability: Origins, methods, and interpretive caveats. Psychophysiology, 34, 623–648
5. Chalmers, J. A., Quintana, D. S., Abbott, M. J.-A., & Kemp, A. H. (2014). Anxiety disorders are associated with reduced heart rate variability: A meta-analysis. Frontiers in Psychiatry, 5, 80
6. Chang, H. A., Chang, C. C., Tzeng, N. S., Kuo, T. B., Lu, R. B., & Huang, S. Y. (2013). Generalized anxiety disorder, comorbid major depression and heart rate variability: A case-control study in Taiwan. Psychiatry Investigation, 10, 326–335
7. Cleary, P., & Guy, W. (1977). Factor analysis of the Hamilton depression scale. Drugs Under Experimental and Clinical Research, 1, 115–120
8. Domschke, K., Deckert, J., Arolt, V., & Baune, B. T. (2010). Anxious versus non-anxious depression: Difference in treatment outcome. Journal of Psychopharmacology, 24, 621–622
9. Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., … Trivedi, M. H. (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. American Journal of Psychiatry, 165, 342–351
10. Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., … Whiteford, H. A. (2013). Burden of depressive disorders by country, sex, age, and year: Findings from the Global Burden of Disease Study 2010. PLoS Medicine, 10(11)e1001547
11. Friedman, B. H. (2007). An autonomic flexibility-neurovisceral integration model of anxiety and cardiac vagal tone. Biological Psychology, 74, 185–199
12. Gatt, J. M., Nemeroff, C. B., Schofield, P. R., Paul, R. H., Clark, C. R., Gordon, E., & Williams, L. M. (2010). Early life stress combined with serotonin 3a receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biological Psychiatry, 68, 818–824
13. Goedhart, A. D., van der Sluis, S., Houtveen, J. H., Willemsen, G., & de Geus, E. J. C. (2007). Comparison of time and frequency domain measures of RSA in ambulatory recordings. Psychophysiology, 44, 203–215
14. Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015). The economic burden of adults with major depressive disorder in the United States (2005 and 2010). Journal of Clinical Psychiatry, 76, 155–162
15. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56–62
16. Hill, L. K., Hu, D. D., Koenig, J., Sollers, J. J., Kapuku, G., Wang, X., … Thayer, J. F. (2015). Ethnic differences in resting heart rate variability: A systematic review and meta-analysis. Psychosomatic Medicine, 77, 16–25
17. Kemp, A. H., Brunoni, A. R., Santos, I. S., Nunes, M. A., Dantas, E. M., Carvalho de Figueiredo, R., … Thayer, J. F. (2014). Effects of depression, anxiety, comorbidity, and antidepressants on resting-state heart rate and its variability: An ELSA-Brasil cohort baseline study. American Journal of Psychiatry, 171, 1328–1334
18. Kemp, A. H., Gordon, E., Rush, A. J., & Williams, L. M. (2008). Improving the prediction of treatment response in depression: Integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectrums, 13(12), 1066–1086
19. Kemp, A. H., Quintana, D. S., Felmingham, K. L., Matthews, S., & Jelinek, H. F. (2012). Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: Implications for cardiovascular risk. PLoS One, 7, e30777
20. Kemp, A. H., Quintana, D. S., Gray, M. A., Felmingham, K. L., Brown, K., & Gatt, J. M. (2010). Impact of depression and antidepressant treatment on heart rate variability: A review and meta-analysis. Biological Psychiatry, 67, 1067–1074
21. Kierlin, L., & Yan-Go, F. (2009). Heart rate variability and depression: Sleep-related breathing disorders as confounder? Archives of General Psychiatry, 66, 915
22. Koenig, J., Jarczok, M. N., Warth, M., Ellis, R. J., Bach, C., Hillecke, T. K., & Thayer, J. F. (2014). Body mass index is related to autonomic nervous system activity as measured by heart rate variability: A replication using short term measurements. The Journal of Nutrition, Health, and Aging, 18, 300–302
23. Koslow, S. H., Wang, Y., Palmer, D. M., Gordon, E., & Williams, L. M. (2013). BRAINnet: A standardized global human brain project. Technology and Innovation, 15, 17–29
24. Licht, C. M. M., de Geus, E. J. C., van Dyck, R., & Penninx, B. W. J. H. (2009). Association between anxiety disorders and heart rate variability in The Netherlands Study of Depression and Anxiety (NESDA). Psychosomatic Medicine, 71, 508–518
25. Licht, C. M. M., de Geus, E. J. C., van Dyck, R., & Penninx, B. W. J. H. (2010). Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biological Psychiatry, 68, 861–868
26. Licht, C. M., de Geus, E. J., Zitman, F. G., Hoogendijk, W. J., van Dyck, R., & Penninx, B. W. (2008). Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Archives of General Psychiatry, 65, 1358–1367
27. Nelson, J. C. (2008). Anxious depression and response to treatment. American Journal of Psychiatry, 165, 297–299
28. Olbrich, S., Tränkner, A., Surova, G., Gevirtz, R., Gordon, E., Hegerl, U., & Arns, M. (2016). CNS- and ANS-arousal predict response to antidepressant medication: Findings from the randomized iSPOT-D study. Journal of Psychiatric Research, 73, 108–155
29. Pan, J., & Tompkins, W. J. (1985). A real-time QRS detection algorithm. IEEE Transactions on Biomedical Engineering, BME-32, 230–236
30. Papakostas, G. I., & Larsen, K. (2011). Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram. European Archives of Psychiatry and Clinical Neuroscience, 261, 147–156
31. Porges, S. W. (1995). Orienting in a defensive world: Mammalian modifications of our evolutionary heritage. A Polyvagal Theory. Psychophysiology, 32, 301–318
32. Rottenberg, J. (2007). Cardiac vagal control in depression: A critical analysis. Biological Psychology, 74, 200–211
33. Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., … Keller, M. B. (2003). The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biological Psychiatry, 54, 573–583
34. Saveanu, R., Etkin, A., Duchemin, A.-M., Goldstein-Piekarski, A., Gyurak, A., Debattista, C., … Williams, L. M. (2015). The international Study to Predict Optimized Treatment in Depression (iSPOT-D): Outcomes from the acute phase of antidepressant treatment. Journal of Psychiatric Research, 61, 1–12
35. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., & Weiller, E., … Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry, 59(Suppl. 20), 22–33
36. Thayer, J. F., Åhs, F., Fredrikson, M., Sollers, J. J., III, & Wager, T. D. (2012). A meta-analysis of heart rate variability and neuroimaging studies: Implications for heart rate variability as a marker of stress and health. Neuroscience and Biobehavioral Reviews, 36, 747–756
37. Thayer, J. F., & Lane, R. D. (2009). Claude Bernard and the heart-brain connection: Further elaboration of a model of neurovisceral integration. Neuroscience and Biobehavioral Reviews, 33, 81–88
38. Trajković, G., Starčević, V., Latas, M., Leštarević, M., Ille, T., Bukumirić, Z., & Marinković, J. (2011). Reliability of the Hamilton Rating Scale for Depression: A meta-analysis over a period of 49 years. Psychiatry Research, 189, 1–9
39. Trivedi, M. H., Rush, A. J., Ibrahim, H. M., Carmody, T. J., Biggs, M. M., Suppes, T., … Witte, B. (2004). The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation. Psychological Medicine, 34, 73–82
40. Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., & Ritz, L. (2006). … STAR*D Study TeamEvaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry, 163, 28–40
41. Uher, R., Dernovsek, M. Z., Mors, O., Hauser, J., Souery, D., Zobel, A., … Farmer, A. (2011). Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of Affective Disorders, 132, 112–120
42. Walker, E. R., McGee, R. E., & Druss, B. G. (2015). Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis. JAMA Psychiatry, 72, 334–341
43. Watkins, L. L., Grossman, P., Krishnan, R., & Blumenthal, J. A. (1999). Anxiety reduces baroreflex cardiac control in older adults with major depression. Psychosomatic Medicine, 61, 334–340
44. Williams, L. M., Rush, A. J., Koslow, S. H., Wisniewski, S. R., Cooper, N. J., Nemeroff, C. B., … Gordon, E. (2011). International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: Rationale and protocol. Trials, 12, 4
45. Wisniewski, S. R., Rush, A. J., Balasubramani, G. K., Trivedi, M. H., Nierenberg, A. A., & STAR*D Investigators. (2006). Self-rated global measure of the frequency, intensity, and burden of side effects. Journal of Psychiatric Practice, 12, 71–79
46. World Health Organization. (2017). Depression and other common mental disorders: Global health estimates. Geneva, Switzerland: World Health Organization. Retrieved from https://apps.who.int/iris/bitstream/handle/10665/254610/WHOMSD?sequence=1